PROCEPT BioRobotics Corp

PRCT

PROCEPT BioRobotics Corp

PRCT

Insider Sentiment (TTM):

Last Purchase:2026-03-09Last Sale:2026-06-08Shares Purchased (TTM):98,699Shares Sold (TTM):24,229

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:50,930,793Shares Outstanding:56,511,000Institutional Ownership Pct.:90.13%

Earnings Market Reaction:

Filing Date:2026-08-05Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	228	246	287	294	303	316	334	197	214	226	257	287
Restricted Cash Current	-	-	-	-	-	-	-	-	-	-	0	1
Accounts Receivable Net Current	108	96	84	85	81	79	83	69	59	56	48	35
Inventory Net	77	78	71	67	67	62	56	51	44	42	40	42
Prepaid Expense And Other Assets Current	8	8	10	9	8	8	8	6	5	6	5	4
Assets Current	420	428	450	455	458	466	482	323	322	329	351	369
Restricted Cash Noncurrent	3	3	3	3	3	3	3	3	3	3	3	3
Property Plant And Equipment Net	32	32	30	30	29	28	27	27	28	28	29	27
Operating Lease Right Of Use Asset	17	17	18	18	18	19	19	19	20	20	20	21
Intangible Assets Net Including Goodwill	1	1	1	1	1	1	1	1	1	1	1	1
Other Assets Noncurrent	7	6	6	5	4	3	3	1	1	1	1	0
Assets	479	487	508	512	513	519	534	374	374	383	405	421
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	15	19	17	11	12	15	10	15	10	10	13	14
Accrued Salaries Current	20	18	23	22	16	15	22	19	15	11	17	13
Contract With Customer Liability Current	14	14	13	11	10	10	10	8	7	6	6	5
Operating Lease Liability Current	3	2	2	2	2	2	2	2	2	2	2	2
Derivative Liabilities Current	-	-	0	0	0	2	2	2	2	2	2	-
Other Liabilities Current	12	10	10	8	10	8	8	8	8	8	6	8
Liabilities Current	64	64	66	54	50	52	53	54	43	39	46	41
Long Term Debt Noncurrent	52	52	52	52	52	51	51	51	51	51	51	51
Operating Lease Liability Noncurrent	23	24	25	25	26	26	27	27	28	28	26	27
Other Liabilities Noncurrent	0	0	0	1	0	0	0	0	0	1	1	-
Liabilities	139	139	142	131	127	130	132	133	123	119	124	122
Derivative Liabilities Noncurrent	-	-	-	-	-	-	-	-	-	-	0	2
Contract With Customer Liability Noncurrent	-	-	-	-	-	-	-	-	-	-	-	1
Stockholders Equity
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	1,040	1,021	1,007	992	976	960	948	768	758	744	735	726
Accumulated Other Comprehensive Income Loss Net Of…	0	-0	0	0	-0	0	0	-0	-0	0	0	-0
Retained Earnings Accumulated Deficit	-700	-673	-642	-612	-590	-571	-546	-527	-506	-481	-455	-427
Stockholders Equity	340	348	366	380	386	389	402	241	252	264	281	299
Liabilities And Stockholders Equity	479	487	508	512	513	519	534	374	374	383	405	421
Preferred Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Authorized	10	10	10	10	10	10	10	10	10	10	10	10
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	300	300	300	300	300	300	300	300	300	300	300	300
Common Stock Shares Issued	57	57	56	56	56	55	55	52	52	51	51	50
Shares Outstanding	57	57	56	56	56	55	55	52	52	51	51	50

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	20.63%	-9.65%	-20.05%	-	-	-	-	-	-	-	-	-
2025	3.16%	8.27%	4.91%	1.47%	-7.40%	-11.62%	0.22%	2.53%	-7.85%	9.14%	6.39%	10.54%
2024	8.36%	-2.95%	9.28%	38.27%	48.12%	20.16%	2.86%	-10.80%	-16.46%	-10.64%	-18.44%	-10.69%
2023	-	-	-	-	-	-	8.40%	29.01%	39.65%	-3.48%	1.62%	37.88%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	6.55	6.73	6.85	8.44	9.21	8.95	9.07	6.02	7.51	8.52	7.63	8.91
Quick Ratio	5.23	5.37	5.62	7.03	7.71	7.60	7.85	4.95	6.37	7.29	6.65	7.80
Working Capital	356.09M	364.40M	384.58M	400.85M	408.34M	413.73M	428.71M	269.34M	279.05M	290.54M	304.64M	327.31M
Leverage & Debt
Debt to Equity	0.41	0.40	0.39	0.35	0.33	0.33	0.33	0.55	0.49	0.45	0.44	0.41
Interest Coverage TTM	-32.88	-30.91	-28.96	-25.28	-23.64	-24.00	-23.09	-24.53	-25.99	-26.11	-27.33	-28.01
Debt Ratio	0.29	0.29	0.28	0.26	0.25	0.25	0.25	0.36	0.33	0.31	0.31	0.29
Efficiency & Turnover
Asset Turnover TTM	0.68	0.64	0.59	0.68	0.62	0.55	0.48	0.50	0.55	0.47	0.38	0.31
Days Sales Outstanding TTM	101.94	99.55	98.95	93.44	92.75	99.15	107.20	94.67	95.18	89.57	85.29	74.42
Receivables Turnover TTM	3.58	3.67	3.69	3.91	3.94	3.68	3.40	3.86	3.83	4.08	4.28	4.90
Per Share Metrics
Diluted EPS TTM	-1.92	-1.81	-1.72	-1.52	-1.52	-1.64	-1.75	-1.92	-2.01	-2.03	-2.24	-2.21
Free Cash Flow Per Share TTM	-1.10	-1.43	-1.05	-1.09	-1.27	-1.61	-1.99	-1.99	-2.12	-2.47	-2.82	-2.60
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	64.22%	63.97%	63.70%	64.55%	64.19%	62.71%	61.07%	57.39%	54.73%	53.47%	52.17%	51.96%
Operating Profit Margin TTM	-33.86%	-33.86%	-33.71%	-30.85%	-33.37%	-38.70%	-43.04%	-53.27%	-62.10%	-69.37%	-80.16%	-89.92%
Net Profit Margin TTM	-32.54%	-31.82%	-31.02%	-28.20%	-30.60%	-36.20%	-40.72%	-50.07%	-58.73%	-66.12%	-77.76%	-91.56%
Growth Metrics
Net Revenue Growth (1Y)	22.69%	29.26%	37.22%	50.07%	55.71%	59.36%	64.84%	71.71%	73.74%	83.44%	81.55%	51.07%
Net Income Growth (1Y)	30.44%	13.62%	4.55%	-15.47%	-18.87%	-12.75%	-13.68%	-6.10%	-0.81%	4.99%	21.51%	1.75%
EPS Growth (1Y)	26.73%	10.41%	-1.89%	-21.11%	-24.46%	-18.95%	-21.74%	-12.78%	-13.22%	-7.24%	14.16%	-5.98%
Valuation Metrics
P/E TTM	-11.74	-13.79	-18.28	-23.51	-37.95	-35.47	-45.91	-41.64	-30.41	-24.39	-18.70	-14.87
P/B TTM	3.79	4.07	4.78	5.23	8.28	8.22	10.43	17.28	12.53	9.55	7.05	5.29
P/S TTM	3.82	4.39	5.67	6.63	11.62	12.84	18.70	20.85	17.86	16.13	14.54	13.62
Market Cap	1.29B	1.41B	1.75B	1.99B	3.19B	3.20B	4.20B	4.17B	3.15B	2.52B	1.98B	1.59B
Enterprise Value	1.11B	1.22B	1.51B	1.74B	2.94B	2.93B	3.91B	4.02B	2.99B	2.34B	1.77B	1.35B
Calculated Values
Free Cash Flow TTM	-62.70M	-80.57M	-58.34M	-60.91M	-70.46M	-88.21M	-103.62M	-103.57M	-109.24M	-126.17M	-133.21M	-125.74M
Net Debt	-179.24M	-197.02M	-237.93M	-245.75M	-251.19M	-267.75M	-285.29M	-148.36M	-162.69M	-177.24M	-208.92M	-239.60M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-08Sale

Owner: Templin, Barry L

Title: EVP, Chief Technology Officer

Shares: 358

Price/Share: $28.48

Value: $10,195.84

Shares Owned: 68,953

Relationship: Officer

Ownership: Direct

2026-06-08Sale

Owner: Waters, Kevin

Title: EVP, CFO

Shares: 357

Price/Share: $28.48

Value: $10,167.36

Shares Owned: 151,201

Relationship: Officer

Ownership: Direct

2026-06-08Sale

Owner: Nouri, Alaleh

Title: EVP, CLO, CORP. SEC.

Shares: 285

Price/Share: $28.48

Value: $8,116.80

Shares Owned: 105,069

Relationship: Officer

Ownership: Direct

2026-03-19Sale

Owner: Nouri, Alaleh

Title: EVP, CLO, CORP. SEC.

Shares: 5,363

Price/Share: $25.98

Value: $139,330.74

Shares Owned: 105,354

Relationship: Officer

Ownership: Direct

2026-03-17Sale

Owner: Nouri, Alaleh

Title: EVP, CLO, CORP. SEC.

Shares: 304

Price/Share: $28.15

Value: $8,557.60

Shares Owned: 110,717

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-08	Templin, Barry L	Officer	EVP, Chief Technology Officer	Direct	Sale	358	28.48	$10,195.84	68,953	4
2026-06-08	Waters, Kevin	Officer	EVP, CFO	Direct	Sale	357	28.48	$10,167.36	151,201	4
2026-06-08	Nouri, Alaleh	Officer	EVP, CLO, CORP. SEC.	Direct	Sale	285	28.48	$8,116.80	105,069	4
2026-03-19	Nouri, Alaleh	Officer	EVP, CLO, CORP. SEC.	Direct	Sale	5,363	25.98	$139,330.74	105,354	4
2026-03-17	Nouri, Alaleh	Officer	EVP, CLO, CORP. SEC.	Direct	Sale	304	28.15	$8,557.60	110,717	4
2026-03-17	Waters, Kevin	Officer	EVP, CFO	Direct	Sale	706	28.15	$19,873.90	151,558	4
2026-03-10	Nouri, Alaleh	Officer	EVP, CLO, CORP. SEC.	Direct	Sale	3,243	26.17	$84,869.31	111,021	4
2026-03-09	Desai, Antal Rohit	Director	-	Indirect	Purchase	98,699	24.80	$2,447,735.20	426,262	4
2026-03-06	Waters, Kevin	Officer	EVP, CFO	Direct	Sale	6,721	23.70	$159,287.70	152,264	4
2026-03-06	Nouri, Alaleh	Officer	EVP, CLO, CORP. SEC.	Direct	Sale	6,892	23.70	$163,340.40	114,264	4
2025-08-13	Moll, Frederic H	Director	-	Direct	Purchase	20,000	39.26	$785,200.00	863,159	4
2025-06-12	Desai, Antal Rohit	Director	-	Indirect	Sale	25,000	61.80	$1,545,000.00	14,363	4
2025-06-06	Shiblaq, Hisham	Officer	EVP, Chief Comm. Officer	Direct	Sale	20,000	64.57	$1,291,400.00	63,133	4
2025-06-05	Desai, Antal Rohit	Director	-	Indirect	Sale	25,000	64.48	$1,612,000.00	89,363	4
2025-03-18	Shiblaq, Hisham	Officer	EVP, Chief Comm. Officer	Direct	Sale	247	57.06	$14,093.82	63,133	4
2025-03-18	Waters, Kevin	Officer	EVP, CFO	Direct	Sale	733	57.06	$41,824.98	107,991	4
2025-03-18	Nouri, Alaleh	Officer	EVP, CLO, CORP. SEC.	Direct	Sale	316	57.06	$18,030.96	61,473	4
2025-03-18	Zadno, Reza	Director,Officer	President, CEO	Direct	Sale	5,475	57.06	$312,403.50	173,070	4
2025-03-06	Zadno, Reza	Director,Officer	President, CEO	Direct	Sale	15,916	61.31	$975,809.96	178,545	4
2025-03-06	Nouri, Alaleh	Officer	EVP, CLO, CORP. SEC.	Direct	Sale	3,641	61.31	$223,229.71	61,789	4
2025-03-06	Waters, Kevin	Officer	EVP, CFO	Direct	Sale	3,662	61.31	$224,517.22	108,724	4
2025-03-06	Shiblaq, Hisham	Officer	EVP, Chief Comm. Officer	Direct	Sale	3,588	61.31	$219,980.28	63,380	4
2024-12-04	Zadno, Reza	Director,Officer	President, CEO	Direct	Sale	26,423	97.57	$2,578,092.11	152,762	4
2024-12-04	Nouri, Alaleh	Officer	EVP, CLO, CORP. SEC.	Direct	Sale	28,092	97.00	$2,724,924.00	52,472	4
2024-11-27	Zadno, Reza	Director,Officer	President, CEO	Direct	Sale	26,420	98.61	$2,605,276.20	179,185	4
2024-11-20	Zadno, Reza	Director,Officer	President, CEO	Direct	Sale	26,420	92.94	$2,455,474.80	205,605	4
2024-11-13	Zadno, Reza	Director,Officer	President, CEO	Direct	Sale	26,420	94.23	$2,489,556.60	232,025	4
2024-11-07	Desai, Antal Rohit	Director	-	Indirect	Sale	34,000	95.83	$3,258,220.00	164,363	4
2024-10-30	Zadno, Reza	Director,Officer	President, CEO	Direct	Sale	288,461	91.00	$26,249,951.00	258,445	4
2024-10-15	Waters, Kevin	Officer	EVP, CFO	Direct	Sale	25,000	72.96	$1,824,000.00	96,096	4
2024-09-16	Waters, Kevin	Officer	EVP, CFO	Direct	Sale	25,000	82.67	$2,066,750.00	96,096	4
2024-09-12	Desai, Antal Rohit	Director	-	Indirect	Sale	44,867	79.33	$3,559,299.11	197,453	4
2024-09-05	Desai, Antal Rohit	Director	-	Indirect	Sale	13,305	76.64	$1,019,695.20	317,518	4
2024-06-17	Nouri, Alaleh	Officer	EVP, CLO, CORP. SEC.	Direct	Sale	10,000	62.67	$626,700.00	52,472	4
2024-06-10	Shiblaq, Hisham	Officer	EVP, Chief Comm. Officer	Direct	Sale	26,046	68.24	$1,777,379.04	55,860	4
2024-05-03	Nouri, Alaleh	Officer	EVP, CLO, CORP. SEC.	Direct	Sale	30,432	62.47	$1,901,087.04	62,472	4
2024-05-01	Krummel, Thomas M	Director	-	Direct	Sale	20,000	60.00	$1,200,000.00	45,631	4
2024-03-18	Zadno, Reza	Director,Officer	President, CEO	Direct	Sale	5,391	48.83	$263,242.53	241,319	4
2024-03-18	Waters, Kevin	Officer	EVP, CFO	Direct	Sale	1,024	48.83	$50,001.92	102,149	4
2024-03-18	Nouri, Alaleh	Officer	EVP, CLO, CORP. SEC.	Direct	Sale	441	48.83	$21,534.03	62,472	4
2024-03-18	Shiblaq, Hisham	Officer	EVP, Chief Comm. Officer	Direct	Sale	244	48.83	$11,914.52	55,860	4
2024-03-06	Waters, Kevin	Officer	EVP, CFO	Direct	Sale	3,435	46.67	$160,311.45	49,416	4
2024-03-06	Zadno, Reza	Director,Officer	President, CEO	Direct	Sale	9,179	46.67	$428,383.93	246,710	4
2024-03-06	Nouri, Alaleh	Officer	EVP, CLO, CORP. SEC.	Direct	Sale	2,749	46.67	$128,295.83	62,913	4
2024-03-06	Shiblaq, Hisham	Officer	EVP, Chief Comm. Officer	Direct	Sale	1,759	46.67	$82,092.53	56,104	4
2024-03-04	Krummel, Thomas M	Director	-	Direct	Sale	20,000	48.60	$972,000.00	65,631	4
2024-02-12	Waters, Kevin	Officer	EVP, CFO	Direct	Sale	22,349	50.16	$1,121,025.84	33,523	4
2024-02-09	Nouri, Alaleh	Officer	EVP, CLO, CORP. SEC.	Direct	Sale	14,694	49.97	$734,259.18	47,351	4
2024-02-09	Waters, Kevin	Officer	EVP, CFO	Direct	Sale	28,677	50.09	$1,436,430.93	33,523	4
2024-01-09	Waters, Kevin	Officer	EVP, CFO	Direct	Sale	17,310	45.07	$780,161.70	33,523	4
2024-01-09	Nouri, Alaleh	Officer	EVP, CLO, CORP. SEC.	Direct	Sale	16,000	44.97	$719,520.00	47,351	4
2023-12-15	Nouri, Alaleh	Officer	EVP, CLO, CORP. SEC.	Direct	Sale	11,796	42.97	$506,874.12	46,933	4
2023-12-13	Waters, Kevin	Officer	EVP, CFO	Direct	Sale	71,465	40.05	$2,862,173.25	33,523	4
2023-12-08	Waters, Kevin	Officer	EVP, CFO	Direct	Sale	6,888	40.02	$275,657.76	33,523	4
2023-12-06	Nouri, Alaleh	Officer	EVP, CLO, CORP. SEC.	Direct	Sale	6,096	39.96	$243,596.16	46,933	4
2023-12-06	Moll, Frederic H	Director	-	Direct	Sale	79,000	38.87	$3,070,730.00	808,233	4
2023-11-13	Wood, Morgan Colby	Director	-	Direct	Sale	25,000	32.19	$804,750.00	112,425	4
2023-07-27	Nouri, Alaleh	Officer	EVP, CLO, CORP. SEC.	Direct	Sale	7,903	40.00	$316,120.00	46,933	4
2023-06-15	Waters, Kevin	Officer	EVP, CFO	Direct	Sale	22,631	35.12	$794,800.72	33,523	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

90.13%

Inst. Shares: 50,930,793

Shares Outstanding: 56,511,000

2025-12-31

86.91%

Inst. Shares: 48,274,078

Shares Outstanding: 55,544,000

2025-09-30

95.96%

Inst. Shares: 53,473,374

Shares Outstanding: 55,727,000

2025-06-30

87.91%

Inst. Shares: 48,743,562

Shares Outstanding: 55,445,000

2025-03-31

82.89%

Inst. Shares: 45,522,183

Shares Outstanding: 54,917,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	50,930,793	56,511,000	90.13%
2025-12-31	48,274,078	55,544,000	86.91%
2025-09-30	53,473,374	55,727,000	95.96%
2025-06-30	48,743,562	55,445,000	87.91%
2025-03-31	45,522,183	54,917,000	82.89%
2024-12-31	45,724,674	52,125,000	87.72%
2024-09-30	40,982,625	52,011,000	78.80%
2024-06-30	38,457,601	51,622,000	74.50%
2024-03-31	39,003,307	51,011,000	76.46%
2023-12-31	37,977,125	47,255,000	80.37%
2023-09-30	36,760,009	48,310,000	76.09%
2023-06-30	30,245,902	45,160,000	66.97%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

PROCEPT BioRobotics Corp (PRCT) — SEC Financial Statements & Analysis

PROCEPT BioRobotics Corp (PRCT) is a surgical & medical instruments & apparatus company, incorporated in DE. PROCEPT BioRobotics Corp trades on Nasdaq as: PRCT. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), PROCEPT BioRobotics Corp reported a 22.69% year-over-year revenue growth, a Gross Profit Margin of 64.22% (TTM), a Debt-to-Equity ratio of 0.41x, a Price-to-Sales (P/S) ratio of 3.82x (TTM), a Price-to-Book (P/B) ratio of 3.79x (TTM), at a market cap of $1.29B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 22.69%
Gross Profit Margin TTM: 64.22%
Debt To Equity: 0.41x
P/S TTM: 3.82x
P/B TTM: 3.79x
Market Cap: $1.29B

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is PROCEPT BioRobotics Corp in?

PROCEPT BioRobotics Corp (PRCT) operates in the Surgical & Medical Instruments & Apparatus industry.

What is PRCT's market cap?

PROCEPT BioRobotics Corp (PRCT) has a market capitalization of $1.29B as of 2026-06-30.

What exchange does PRCT trade on?

PROCEPT BioRobotics Corp (PRCT) trades on the Nasdaq.

Where is PROCEPT BioRobotics Corp incorporated?

PROCEPT BioRobotics Corp is incorporated in DE.